Scarica l'app Stockscreener
7.94
0.51%
0.04
Dopo l'orario di chiusura:
7.79
-0.15
-1.89%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$7.90
Aprire:
$7.855
Volume 24 ore:
958.39K
Relative Volume:
0.75
Capitalizzazione di mercato:
$322.66M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-9.6829
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
+7.59%
1M Prestazione:
-42.04%
6M Prestazione:
-75.55%
1 anno Prestazione:
-83.40%
Intervallo 1D:
$7.70
$7.975
Intervallo di 1 settimana:
$7.24
$8.095
Portata 52W:
$6.32
$58.23
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.94 | 321.03M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
125.64 | 218.92B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.21 | 152.62B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.66 | 153.22B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.32 | 117.89B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
75.80 | 45.12B | 5.54B | 4.18B | 623.10M | 7.00 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
Contact Levi & Korsinsky by September 22, 2025 to Join Class Action Against RxSight, Inc. (RXST) - TradingView
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - The Globe and Mail
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - Benzinga
RxSight Faces Class Action for Alleged Fraud - TipRanks
RXST CLASS ACTION: Decline in LAL Utilization leads to - GlobeNewswire
What analysts say about RxSight Inc. stockTriple-digit growth rates - Autocar Professional
Medical Device Co. Faces Investor Suit Over Sales Decline - Law360
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
Is RxSight Inc. a good long term investmentSignificant capital appreciation - jammulinksnews.com
RXST INVESTOR ALERT: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Globe and Mail
RXST ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. Investors - TradingView
RxSight, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
RXST LEGAL UPDATE: RxSight, Inc. Sued for Fraud Amid Declining LAL Utilization -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline - Business Wire
What drives RxSight Inc. stock priceDynamic capital growth - Autocar Professional
RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - MarketScreener
RxSight Investor Sues After 2025 Revenue Cut on Eye Device Sales - Bloomberg Law News
Law Offices of Howard G. Smith Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action - The Globe and Mail
Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Globe and Mail
RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - FinancialContent
Shareholders Filed a Lawsuit Against RxSight for Overstating Demand - TradingView
RxSight ($RXST) Sales Execution Failures, Guidance Cut, and Executive Turnover Case - TradingView
Shareholder Alert: Robbins LLP Informs Investors of the RxSight,Inc. Securities Fraud Class Action Lawsuit - ACCESS Newswire
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
RXST LOSS ALERT: Lose Money on RxSight, Inc. (NASDAQ: - GlobeNewswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights – RXST - The Globe and Mail
RxSight Shares Fall 38% on Q2 ‘Underperformance’ - Orange County Business Journal
RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm - ETX View
RXST SECURITIES NEWS: Did RxSight, Inc. (NASDAQ:RXST) - GlobeNewswire
RxSight Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Time To Worry? Analysts Just Downgraded Their RxSight, Inc. (NASDAQ:RXST) Outlook - simplywall.st
What Does The Future Hold For RxSight, Inc. (NASDAQ:RXST)? These Analysts Have Been Cutting Their Estimates - Yahoo Finance
Revenue Downgrade: Here's What Analysts Forecast For RxSight, Inc. (NASDAQ:RXST) - 富途牛牛
Midday Stock Roundup: loanDepot Shoots Up 16% - Orange County Business Journal
RXST INVESTIGATION: RxSight, Inc. (NASDAQ:RXST) 38% Stock - GlobeNewswire
(RXST) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.03%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):